Phenominer Database Results (24 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Time Value Record ID Study ID
BB.SHR-(D6Rat184-D6Rat3)/K blood CD8 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD8-positive T cell quantity both 90 days 30 0.7 % 0.13 0.7 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84628 324
BB.SHR-(D6Rat184-D6Rat3)/K blood RT6.1 positive cell count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. T cell quantity both 90 days 10 1.7 % 0.13 0.4 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84635 324
BB.SHR-(D6Rat184-D6Rat3)/K blood T lymphocyte count to total leukocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. T cell quantity both 90 days 10 10.4 % 0.95 3.0 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75602 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD45RC(high) CD4 T cell count to CD45RC(low) CD4 T cell count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 10 0.05 % 0.01 0.02 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84689 324
BB.SHR-(D6Rat184-D6Rat3)/K blood RT6.1 positive cell count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. T cell quantity both 90 days 30 3.0 % 0.6 3.3 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84634 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD25 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. lymphocyte quantity both 90 days 10 36.6 % 2.18 6.9 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84638 324
BB.SHR-(D6Rat184-D6Rat3)/K blood lymphocyte count control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. lymphocyte quantity both 90 days 10 1.87 x 1000 cells/ul 0.19 0.6 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75596 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD45RC(low) CD4 T lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 10 70.9 % 1.93 6.1 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84686 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD4 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 10 43.3 % 1.9 6.0 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84626 324
BB.SHR-(D6Rat184-D6Rat3)/K blood natural killer cell count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. natural killer cell quantity both 90 days 30 13.3 % 1.15 6.3 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84631 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD25 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. lymphocyte quantity both 90 days 30 65.6 % 3.36 18.4 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84637 324
BB.SHR-(D6Rat184-D6Rat3)/K blood lymphocyte count control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. lymphocyte quantity both 90 days 30 2.02 x 1000 cells/ul 0.15 0.82 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75595 324
BB.SHR-(D6Rat184-D6Rat3)/K blood T lymphocyte count to total leukocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. T cell quantity both 90 days 30 11.0 % 0.82 4.5 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75601 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD45RC(low) CD4 T lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 30 64.6 % 1.61 8.8 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84685 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD4 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 30 37.8 % 2.15 11.8 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84625 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD8 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD8-positive T cell quantity both 90 days 10 0.8 % 0.09 0.3 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84629 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD45RC(high) CD4 T lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 30 4.6 % 0.53 2.9 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84682 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD45RC(high) CD4 T cell count to CD45RC(low) CD4 T cell count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 30 0.08 % 0.01 0.05 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84688 324
BB.SHR-(D6Rat184-D6Rat3)/K white blood cell count control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. leukocyte quantity both 90 days 30 3.77 x 1000 cells/ul 214.34 1174.0 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75604 324
BB.SHR-(D6Rat184-D6Rat3)/K white blood cell count control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. leukocyte quantity both 90 days 10 2.98 x 1000 cells/ul 0.28 0.87 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75605 324
BB.SHR-(D6Rat184-D6Rat3)/K blood natural killer cell count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. natural killer cell quantity both 90 days 10 14.7 % 0.7 2.2 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84632 324
BB.SHR-(D6Rat184-D6Rat3)/K blood B lymphocyte count to total leukocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. B cell quantity both 90 days 30 37.7 % 2.03 11.1 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75598 324
BB.SHR-(D6Rat184-D6Rat3)/K blood B lymphocyte count to total leukocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. B cell quantity both 90 days 10 31.0 % 1.9 6.0 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75599 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD45RC(high) CD4 T lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 10 3.2 % 0.38 1.2 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84683 324